Literature DB >> 32546195

Micronutrient status of COVID-19 patients: a critical consideration.

Anitra C Carr1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32546195      PMCID: PMC7296900          DOI: 10.1186/s13054-020-03085-0

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
As the novel coronavirus (SARS-CoV-2) pandemic continues to grip the world, ongoing research is highlighting the factors associated with higher risk of severe morbidity and mortality. These factors include older age, male, and comorbidities, including obesity [1]. Relatively little attention, however, is paid to the micronutrient status of COVID-19 patients. Micronutrients are vitamins and specific minerals that are critical to the proper structure and functioning of numerous proteins, enzymes, physiological processes, and signaling pathways within the body. Without these micronutrients, these essential processes cease to function properly, and this contributes to morbidity and, in cases of severe deficiency, mortality. The term “micronutrients” refers to the fact that these nutrients are required in small, usually microgram, amounts daily. However, in critical illness, the requirements for these micronutrients can increase significantly. This is particularly true for vitamin C, which is severely depleted in critically ill patients at admission and is required in gram amounts to replete the patients [2]. Severe respiratory infections, such as pneumonia, are a common complication of severe vitamin C deficiency, and pneumonia is one of the most common causes of mortality in patients with severe vitamin C deficiency [3]. This indicates an important link between vitamin C status and respiratory infections. Vitamin C has numerous important and pleiotropic roles in immune function, including regulation of hundreds of genes in immune cells [3]. Although the vitamin C status of patients with COVID-19 has not yet been reported in the literature, it is known that the vitamin C status of patients with community-acquired pneumonia is severely depleted and is associated with enhanced oxidative stress [4]. However, it is not yet known if vitamin C deficiency is a cause and/or a consequence of severe infection, as the latter results in enhanced requirements for the vitamin. There are numerous factors, in addition to inadequate diet, that are associated with depleted vitamin C status [5]; these include male gender, comorbidities, and obesity, which are also associated with enhanced susceptibility to COVID-19. Therefore, it is important to consider that differences in susceptibility to, and severity of, COVID-19 could be partly due to insufficient micronutrient levels for adequate immune and organ function. As such, it would be of benefit to COVID-19 patients if critical care physicians take this into consideration and test for potential micronutrient insufficiencies in their patients and, if indicated, supplement with adequate amounts to restore normal status and function. This may help improve patient outcomes.
  3 in total

1.  Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes.

Authors:  Anitra C Carr; Patrice C Rosengrave; Simone Bayer; Steve Chambers; Jan Mehrtens; Geoff M Shaw
Journal:  Crit Care       Date:  2017-12-11       Impact factor: 9.097

2.  Patients with Community Acquired Pneumonia Exhibit Depleted Vitamin C Status and Elevated Oxidative Stress.

Authors:  Anitra C Carr; Emma Spencer; Liane Dixon; Stephen T Chambers
Journal:  Nutrients       Date:  2020-05-06       Impact factor: 5.717

3.  Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.

Authors:  Yu Shi; Xia Yu; Hong Zhao; Hao Wang; Ruihong Zhao; Jifang Sheng
Journal:  Crit Care       Date:  2020-03-18       Impact factor: 9.097

  3 in total
  6 in total

1.  Role of micronutrients in the management of coronavirus disease 2019.

Authors:  M AbdAllah; H Ez Elarab; E Raslan; L Saber; E Daoud; M Saber
Journal:  New Microbes New Infect       Date:  2020-10-10

2.  Therapeutic approaches for SARS-CoV-2 infection.

Authors:  Ankur Gupta; Anish Pradhan; Vimal K Maurya; Swatantra Kumar; Angila Theengh; Bipin Puri; Shailendra K Saxena
Journal:  Methods       Date:  2021-05-05       Impact factor: 3.608

3.  Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study.

Authors:  Joël Pincemail; Etienne Cavalier; Corinne Charlier; Jean-Paul Cheramy-Bien; Eric Brevers; Audrey Courtois; Marjorie Fadeur; Smail Meziane; Caroline Le Goff; Benoît Misset; Adelin Albert; Jean-Olivier Defraigne; Anne-Françoise Rousseau
Journal:  Antioxidants (Basel)       Date:  2021-02-07

Review 4.  Vitamins C and D and COVID-19 Susceptibility, Severity and Progression: An Evidence Based Systematic Review.

Authors:  Filippo Migliorini; Raju Vaishya; Jörg Eschweiler; Francesco Oliva; Frank Hildebrand; Nicola Maffulli
Journal:  Medicina (Kaunas)       Date:  2022-07-15       Impact factor: 2.948

Review 5.  Is butyrate a natural alternative to dexamethasone in the management of CoVID-19?

Authors:  Nithin K K; Prakash Patil; Satheesh Kumar Bhandary; Vikram Haridas; Suchetha Kumari N; Sarathkumar E; Praveenkumar Shetty
Journal:  F1000Res       Date:  2021-04-06

Review 6.  Diet and Hygiene in Modulating Autoimmunity During the Pandemic Era.

Authors:  Leila Abdelhamid; Xin M Luo
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.